Company / Current Liabilities per Share
ORAMED PHARMACEUTICALS INC. Current Liabilities per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$0.48
FY2025
5-year range
$0.14 / $1.35
FY2021-FY2025
Trend
+239.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Liabilities per Share changed +239% YoY in FY2025, a notable deviation from the 9-year average annual change of +99%.
Based on SEC 10-K filings.
0.48 in FY2025 with a 5-year CAGR of +12.9%.
Improved from $1.35 to $0.48 over the past 2 years.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- +47.0%
- 5-Year CAGR
- +12.9%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, current liabilities per share increased 239.3% year-over-year.
- Peak current liabilities per share was recorded in FY2023.
- Lowest current liabilities per share in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score 0.91 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.48 | +239.3% |
| FY2024 | $0.14 | -89.5% |
| FY2023 | $1.35 | +793.2% |
| FY2022 | $0.15 | -46.6% |
| FY2021 | $0.28 | +8.1% |
| FY2020 | $0.26 | -14.6% |
| FY2019 | $0.31 | -8.3% |
| FY2018 | $0.33 | -15.0% |
| FY2017 | $0.39 | +25.1% |
| FY2016 | $0.31 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026